Technical Commentary

Total Page:16

File Type:pdf, Size:1020Kb

Technical Commentary TECHNICAL COMMENTARY Policy and law Introduction some reviews may have been limited by journal guidelines. Mental health laws in many countries limit involuntary hospital admissions to patients who Evidence was graded using the Grading of meet an obligatory dangerousness criterion Recommendations Assessment, Development (ODC) for risk to themselves or others. This and Evaluation (GRADE) Working Group policy approach is in use throughout Australia, approach where high quality evidence such as the USA, and some areas of Canada and that gained from randomised controlled trials Europe. Alternative criteria implemented in the (RCTs) may be downgraded to moderate or low UK and other parts of Canada and Europe if review and study quality is limited, if there is allow involuntary treatment in the absence of inconsistency in results, indirect comparisons, dangerousness, on the grounds of an assessed imprecise or sparse data and high probability of need for treatment if the patient is deemed reporting bias. It may also be downgraded if unable to give consent. risks associated with the intervention or other matter under review are high. Conversely, low Method quality evidence such as that gained from We have included only systematic reviews observational studies may be upgraded if effect (systematic literature search, detailed sizes are large, there is a dose dependent methodology with inclusion/exclusion criteria) response or if results are reasonably published in full text, in English, from the year consistent, precise and direct with low 2000 that report results separately for people associated risks (see end of table for an with a diagnosis of schizophrenia and related explanation of these terms)3. The resulting disorders. Reviews were identified by searching table represents an objective summary of the the databases MEDLINE, EMBASE, CINAHL, available evidence, although the conclusions Current Contents, PsycINFO and the Cochrane are solely the opinion of staff of NeuRA library. Hand searching reference lists of (Neuroscience Research Australia). identified reviews was also conducted. When multiple copies of reviews were found, only the most recent version was included. Results Review reporting assessment was guided by the Preferred Reporting Items for Systematic We found one systematic review that met our Reviews and Meta-Analyses (PRISMA) inclusion criteria1. checklist that describes a preferred way to • Moderate to high quality evidence indicates 2 present a meta-analysis . Reviews with less that a requirement for patients to satisfy an than 50% of items checked have been obligatory ‘dangerousness’ criterion to allow excluded from the library. The PRISMA flow compulsory treatment may be associated diagram is a suggested way of providing with a longer duration of untreated psychosis information about studies included and in those regions. excluded with reasons for exclusion. Where no flow diagram has been presented by individual reviews, but identified studies have been described in the text, reviews have been checked for this item. Note that early reviews may have been guided by less stringent reporting checklists than the PRISMA, and that NeuRA Policy and law August 2020 Margarete Ainsworth Building, Barker Street , Randwick NSW 2031. Phone: 02 9399 1000. Email: [email protected] Page 1 To donate, phone 1800 888 019 or visit www.neura.edu.au/donate/schizophrenia TECHNICAL COMMENTARY Policy and law Large MM, Nielssen O, Ryan CJ, Hayes R Mental health laws that require dangerousness for involuntary admission may delay the initial treatment of schizophrenia Social Psychiatry and Psychiatric Epidemiology 2008; 43(3): 251-256 View review abstract online Comparison Duration of untreated psychosis in countries with and without obligatory dangerousness criterion for involuntary treatment. Summary of evidence Moderate to high quality evidence (large samples, unable to assess consistency, precise, direct) indicates longer DUP is associated with a requirement for patients to fill obligatory dangerousness criteria before compulsory admission. Authors conclude that it is likely that at least some of the increase in DUP in regions with an obligatory dangerousness criterion is a direct result of differences in mental health law. Duration of untreated psychosis (DUP) 47 studies, N = 5,849 The mean DUP in samples from regions with an obligatory dangerousness criterion (ODC) was significantly longer than regions without an ODC. Median values were not significantly different. Obligatory dangerousness criterion: Mean 79.5 weeks (95% CI 63.5 to 95.4), weighted mean 77.7 weeks Average median DUP in ODC: 27.5 weeks (95% CI 17.3 to 37.3 weeks), median 28 weeks No- obligatory dangerousness criterion: Mean 55.6 weeks (95% CI 43.4 to 68.8 weeks), weighted mean 55.7 weeks Average median DUP in non-ODC: 19.9 weeks (95% CI 12.9 to 26.9 weeks), median 16 weeks Consistency in results Unable to assess; no measure of consistency is reported. Precision in results Precise Directness of results Direct Explanation of acronyms CI = Confidence Interval, DUP = Duration of Untreated Psychosis, ODC = Obligatory Dangerousness Criterion NeuRA Policy and law August 2020 Margarete Ainsworth Building, Barker Street , Randwick NSW 2031. Phone: 02 9399 1000. Email: [email protected] Page 2 To donate, phone 1800 888 019 or visit www.neura.edu.au/donate/schizophrenia TECHNICAL COMMENTARY Policy and law Explanation of technical terms Prevalence refers to how many existing cases there are at a particular point in time. * Bias has the potential to affect reviews of Incidence refers to how many new cases both RCT and observational studies. Forms of there are per population in a specified time bias include; reporting bias – selective period. Incidence is usually reported as the reporting of results; publication bias - trials number of new cases per 100,000 people per that are not formally published tend to show year. Alternatively some studies present the less effect than published trials, further if number of new cases that have accumulated there are statistically significant differences over several years against a person-years between groups in a trial, these trial results denominator. This denominator is the sum of tend to get published before those of trials individual units of time that the persons in the without significant differences; language bias population are at risk of becoming a case. It – only including English language reports; takes into account the size of the underlying funding bias - source of funding for the population sample and its age structure over primary research with selective reporting of the duration of observation. results within primary studies; outcome Reliability and validity refers to how accurate variable selection bias; database bias - the instrument is. Sensitivity is the proportion including reports from some databases and of actual positives that are correctly identified not others; citation bias - preferential citation (100% sensitivity = correct identification of all of authors. Trials can also be subject to bias actual positives) and specificity is the when evaluators are not blind to treatment proportion of negatives that are correctly condition and selection bias of participants if identified (100% specificity = not identifying 4 trial samples are small . anyone as positive if they are truly not). Weighted mean difference scores refer to mean differences between treatment and † Different effect measures are reported by comparison groups after treatment (or different reviews. occasionally pre to post treatment) and in a randomized trial there is an assumption that Correlation coefficients (eg, r) indicate the both groups are comparable on this measure strength of association or relationship prior to treatment. Standardized mean between variables. They are an indication of differences are divided by the pooled prediction, but do not confirm causality due to standard deviation (or the standard deviation possible and often unforseen confounding of one group when groups are homogenous) variables. An r of 0.10 represents a weak that allows results from different scales to be association, 0.25 a medium association and combined and compared. Each study’s mean 0.40 and over represents a strong difference is then given a weighting association. Unstandardised (b) regression depending on the size of the sample and the coefficients indicate the average change in variability in the data. 0.2 represents a small the dependent variable associated with a 1 effect, 0.5 a medium effect, and 0.8 and over unit change in the dependent variable, represents a large effect4. statistically controlling for the other independent variables. Standardised Odds ratio (OR) or relative risk (RR) refers to regression coefficients represent the change the probability of a reduction (< 1) or an being in units of standard deviations to allow increase (> 1) in a particular outcome in a comparison across different scales. treatment group, or a group exposed to a risk factor, relative to the comparison group. For NeuRA Policy and law August 2020 Margarete Ainsworth Building, Barker Street , Randwick NSW 2031. Phone: 02 9399 1000. Email: [email protected] Page 3 To donate, phone 1800 888 019 or visit www.neura.edu.au/donate/schizophrenia TECHNICAL COMMENTARY Policy and law example, a RR of 0.75 translates to a limit crosses an effect size of 0.5 in either reduction in risk of an outcome of 25% direction, and for binary and correlation data, relative to those not receiving the treatment or an effect size of 0.25. GRADE also not exposed to the risk factor. Conversely, an recommends downgrading the evidence when RR of 1.25 translates to an increased risk of sample size is smaller than 300 (for binary 25% relative to those not receiving treatment data) and 400 (for continuous data), although or not having been exposed to a risk factor. for some topics, this criteria should be An RR or OR of 1.00 means there is no relaxed6. difference between groups. A medium effect is considered if RR > 2 or < 0.5 and a large effect if RR > 5 or < 0.25.
Recommended publications
  • A Resource Guide for Families Dealing with Mental Illness
    This resource guide is provided by: NAMI Michigan For more information, please contact us: 921 N. Washington Ave. Lansing, MI 48906 517.485.4049 800.331.4264 [email protected] www.namimi.org www.facebook.com/namiofmi www.twitter/namiofmi Please help NAMI Michigan continue to serve those affected by mental illness by joining or donating to our organization. Fill out and mail the form below or go to www.nami.org and join online. NAMI Michigan Membership & Donations Whenever possible, we will refer you to a NAMI affiliate in your community for membership. If you have a preference, please indicate below. Name_____________________________________________ Address___________________________________________ _________________________________________________ City_________________________ State______ Zip_______ Phone____________________________________________ E‐Mail____________________________________________ Regular Membership $35 _______________________ Includes National, State & Local Affiliate nearest you Open Door $3 min. For those with financial hardship Donation All donations are tax deductible. NAMI Michigan is a 501 (c)(3) nonprofit organization Mail to: NAMI Michigan 921 N. Washington Lansing, MI 48906 THE NAMI MICHIGAN FAMILY RESOURCE GUIDE Mental Illness: A Family Resource Guide was written for and dedicated to families who have a relative with mental illness. The first edition, published in 1988, came about through the initiative of Yolanda Alvarado and other members of NAMI Michigan who saw the need to share what they knew with other families. The original manuscript was written by Carol Rees of NAMI Washtenaw County. Many family members, individuals living with brain disorders and mental health professionals have contributed to revisions over the years with special thanks due to attorney Bradley Geller and Marjorie Hartnett for the section on voluntary and involuntary treatment and to Dr.
    [Show full text]
  • Mental Health Law
    Mental Health Law January 2017 Syllabus Professor Tovino University of Houston Law Center Health Law and Policy Institute ______________________________________________________________________ General Course Information Course: Mental Health Law Course No.: 5297 Section No.: 25140 Credits: 2 Classroom: TBD Dates: January 2, 3, 4, 5, 6, 9, and 10, 2017 Time: 9:00 a.m. to 12:30 p.m. Instructor: Stacey A. Tovino, JD, PhD E-mail: [email protected] Course Description and Objectives This course will examine a variety of civil and administrative issues pertaining to mental health care access, quality, liability, and finance. Particular attention will be given to federal and state mental health parity law and mandatory mental health and substance use disorder law; federal and state laws protecting the confidentiality of mental health and substance use disorder records; federal and state regulation of interventions such as restraint, seclusion, electroconvulsive therapy, and psychosurgery; state law scope of practice issues for mental health professionals, including psychiatrists, psychologists, social workers, advance nurse practitioners, and counselors; state regulation of involuntary inpatient and outpatient commitment; and civil liability and/or professional discipline for negligent failure to diagnose, negligent misdiagnosis, negligent treatment, negligent referral, sexual and romantic relationships with patients, patient injury following elopement, and patient suicide. Course Materials There are no required or recommended casebooks. All of our course materials, including a variety of federal and state statutes, regulations, and judicial opinions, are on TWEN. Course materials are listed below under Course Schedule. Course Evaluation I will base 100% of your final grade on one anonymous, closed-book, two-hour, final examination, which shall include fifty multiple-choice questions.
    [Show full text]
  • What Can You Do If Someone with a Serious Mental Illness Refuses Treatment? (Updated March 2014)
    _________________Treatment Advocacy Center Backgrounder______________ What Can You Do If Someone with a Serious Mental Illness Refuses Treatment? (updated March 2014) SUMMARY: Some people with schizophrenia and bipolar disorder refuse treatment. The main reason they do so is that they have no awareness of their illness and do not think that they are sick; this is called anosognosia. Some people who refuse treatment can be persuaded to accept it by patiently working with them or by offering them a reward if they do so. Others continue to refuse treatment; in such cases there are a few options which vary by state depending on the laws of that state. The most effective of these options are assisted outpatient treatment (AOT); conditional release; and mental health courts. Assisted Outpatient Treatment (AOT) AOT is a form of outpatient commitment in which mentally ill individuals are told by court order that they can live in the community as long as they follow their treatment plan, but if they do not do so, they can be involuntarily returned to the hospital. It is available in all states except Massachusetts, Connecticut, Maryland, Tennessee, and New Mexico. The criteria for being put on AOT varies somewhat by state but usually includes having had a history of not following treatment plans and becoming dangerous to self or others when not being treated. Examples of AOT are Kendra’s Law in New York and Laura’s Law in California. AOT has been shown to be effective in reducing rehospitalizations, incarcerations, victimizations, episodes of violence, and homelessness. Stettin B. An advocate’s observations on research concerning assisted outpatient treatment.
    [Show full text]
  • The Law of Mental Illness
    DEVELOPMENTS IN THE LAW THE LAW OF MENTAL ILLNESS “[D]oing time in prison is particularly difficult for prisoners with men- tal illness that impairs their thinking, emotional responses, and ability to cope. They have unique needs for special programs, facilities, and extensive and varied health services. Compared to other prisoners, moreover, prisoners with mental illness also are more likely to be ex- ploited and victimized by other inmates.” HUMAN RIGHTS WATCH, ILL-EQUIPPED: U.S. PRISONS AND OFFENDERS WITH MENTAL ILLNESS 2 (2003), available at http://www.hrw.org/reports/2003/usa1003/usa1003.pdf. “[I]ndividuals with disabilities are a discrete and insular minority who have been faced with restrictions and limitations, subjected to a history of purposeful unequal treatment, and relegated to a position of political powerlessness in our society, based on characteristics that are beyond the control of such individuals and resulting from stereotypic assumptions not truly indicative of the individual ability of such indi- viduals to participate in, and contribute to, society . .” Americans with Disabilities Act of 1990, Pub. L. No. 101-336, § 2(a)(7), 104 Stat. 327, 329 (codified at 42 U.S.C. § 12101 (2000)). “We as a Nation have long neglected the mentally ill . .” Remarks [of President John F. Kennedy] on Proposed Measures To Combat Mental Illness and Mental Retardation, PUB. PAPERS 137, 138 (Feb. 5, 1963). “[H]umans are composed of more than flesh and bone . [M]ental health, just as much as physical health, is a mainstay of life.” Madrid v. Gomez, 889 F. Supp. 1146, 1261 (N.D. Cal.
    [Show full text]
  • DEVELOPMENTS in MENTAL HEALTH LAW the Institute of Law, Psychiatry & Public Policy — the University of Virginia
    DEVELOPMENTS IN MENTAL HEALTH LAW The Institute of Law, Psychiatry & Public Policy — The University of Virginia Volume 35, Issue 4 Winter 2016 In This Issue: I. Updates: A. SJ 47 Joint Subcommittee Actions and Recommendations to the 2017 General Assembly Session [p. 1] Work Group #1: System Structure and Financing [p. 1] Work Group #2: Criminal Justice Diversion [p. 5] Work Group #3: Mental Health Crisis and Emergency Services [p. 6] Work Group #4: Housing [p. 7] B. Other Mental Health Related Bills in the 2017 General Assembly [p. 9] II. Article: The Case for Permanent Supportive Housing for Persons with Serious Mental Illness: Improved Lives, Reduced Costs, and Compliance with Federal Law [p.17] III. ILPPP Data Corner: Permanent Supportive Housing: Virginia Investment and Estimated State Cost Avoidance [p.23] IV. Case Law Developments [p.27] Federal Circuit Court Decisions [p.27] Virginia Court Decisions [p.33] State Court Decisions [p.33] V. Institute Programs [p.37] ______________________________________________________ 1 I. Updates A. SJ 47 Joint Subcommittee Actions and Recommendations to the 2017 General Assembly Session As noted in the last issue of DMHL, at the October 26, 2016 meeting of the SJ 47 Joint Subcommittee to Study Mental Health Services in the Commonwealth in the 21st Century the Subcommittee’s Work Groups and members appeared to move closer to adopting a shared vision of a future statewide system of mental health services, while acknowledging the significant obstacles to realizing that vision. Each Work Group chairperson set out recommendations for budget and statutory actions in the 2017 General Assembly session to support a variety of mental health reform measures.
    [Show full text]
  • The Chemical Castration of Recidivist Sex Offenders in Canada: a Matter of Faith
    Dalhousie Law Journal Volume 33 Issue 2 Article 7 10-1-2010 The Chemical Castration of Recidivist Sex Offenders in Canada: A Matter of Faith Matthew R. Kutcher Dalhousie University Follow this and additional works at: https://digitalcommons.schulichlaw.dal.ca/dlj Part of the Criminal Law Commons Recommended Citation Matthew R. Kutcher, "The Chemical Castration of Recidivist Sex Offenders in Canada: A Matter of Faith" (2010) 33:2 Dal LJ 193. This Article is brought to you for free and open access by the Journals at Schulich Law Scholars. It has been accepted for inclusion in Dalhousie Law Journal by an authorized editor of Schulich Law Scholars. For more information, please contact [email protected]. Matthew R. Kutcher* The Chemical Castration of Recidivist Sex Offenders in Canada: A Matter of Faith Chemical castration refers to the use of medication to reduce male testosterone to pre-pubertal levels. Since the mid-20th century reports have detailed this practice in attempts to control pathological sexual behaviour. In 2006, the Canadian Federal Court of Appeal ruled it constitutional for the National Parole Board to require that recidivist sex offenders, if found to be long-term offenders, be chemically castrated under their conditions of release. This paper examines the chemical castration of recidivist sex offenders in Canada through a review of long-term offender hearings reported between 1997 and 2009. The practice is analyzed from ethical, medical and legal perspectives. It is concluded that chemical castration of sex offenders is ethically problematic, that evidence for its effectiveness in preventing recidivism is limited and of poor quality and that judges should avoid excessive reliance on chemical castration when deciding to grant conditional release to recidivist sex offenders.
    [Show full text]
  • Supreme Court of the United States ______JAMES K
    No. 18-6135 IN THE Supreme Court of the United States __________ JAMES K. KAHLER, Petitioner, v. STATE OF KANSAS, Respondent. __________ On Writ of Certiorari to the Supreme Court of Kansas __________ BRIEF OF AMERICAN PSYCHIATRIC ASSOCIATION, AMERICAN PSYCHOLOGICAL ASSOCIATION, AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, THE JUDGE DAVID L. BAZELON CENTER FOR MENTAL HEALTH LAW, AND MENTAL HEALTH AMERICA AS AMICI CURIAE IN SUPPORT OF PETITIONER __________ DAVID W. OGDEN AARON M. PANNER PAUL R.Q. WOLFSON Counsel of Record ALEXANDRA STEWART KEVIN D. HORVITZ WILMER CUTLER PICKERING MICHAEL S. QIN HALE AND DORR LLP KELLOGG, HANSEN, TODD, 1875 Pennsylvania Ave., N.W. FIGEL & FREDERICK, Washington, D.C. 20006 P.L.L.C. (202) 663-6000 1615 M Street, N.W. Suite 400 NATHALIE F.P. GILFOYLE Washington, D.C. 20036 DEANNE M. OTTAVIANO (202) 326-7900 AMERICAN PSYCHOLOGICAL ([email protected]) ASSOCIATION Counsel for American 750 First Street, N.E. Psychiatric Association Washington, D.C. 20002 and American Academy of (202) 336-5500 Psychiatry and the Law Counsel for American Psychological Association June 7, 2019 (Additional Counsel Listed On Inside Cover) IRA ABRAHAM BURNIM JENNIFER MATHIS BAZELON CENTER FOR MENTAL HEALTH LAW 1101 15th Street, N.W. Suite 1212 Washington, D.C. 20005 (202) 467-5730 Counsel for The Judge David L. Bazelon Center for Mental Health Law MARK J. HEYRMAN CLINICAL PROFESSOR OF LAW UNIVERSITY OF CHICAGO LAW SCHOOL 1111 East 60th Street Chicago, Illinois 60637 (773) 702-9611 Counsel for Mental Health America TABLE OF CONTENTS Page TABLE OF AUTHORITIES ...................................... iii INTEREST OF AMICI CURIAE ...............................
    [Show full text]
  • Guideline for Drug Courts on Screening and Assessment
    GUIDELINE FOR DRUG COURTS ON SCREENING AND ASSESSMENT Roger H. Peters1 and Elizabeth Peyton2 Prepared for the American University, Justice Programs Office, in association with the U.S. Department of Justice, Office of Justice Programs, Drug Courts Program Office May 1998 1Associate Professor, Department of Mental Health Law and Policy, the Louis de la Parte Florida Mental Health Institute, University of South Florida. 2Executive Director, National TASC — Treatment Accountability for Safer Communities. i ii Acknowledgments The authors express sincere appreciation to the following persons who volunteered their valuable time and expertise to the development of this document: Hon. William G. Meyer Jody Forman Denver Drug Court Project Charlottesville, VA Denver, CO Marc Pearce Hon. Richard S. Gebelein National Association of Drug Delaware Superior Court Court Professionals Wilmington, DE Alexandria, VA Martin O. Conoley Joseph Carloni Santa Barbara County Probation Pathway Treatment Services Santa Barbara, CA Pensacola, FL Ed Brekke Valerie Moore Los Angeles Superior Court IN ACT, Inc. Los Angeles, CA Portland, OR Caroline Cooper The American University Washington, DC iii iv Table of Contents FOREWORD .................................................................................................................. 1 INTRODUCTION .......................................................................................................... 3 What are the differences between screening and assessment? ................................ 3 Goals of screening
    [Show full text]
  • Mental Health Care Law: Ten Basic Principles
    WHO/MNH/MND/96.9 MENTAL HEALTH CARE LAW: TEN BASIC PRINCIPLES with Annotations Suggesting Selected Actions to Promote their Implementation This is an edited version of a WHO document which lists and describes ten basic principles of mental health care law. It also provides annotations for their implementation in practice. KEY WORDS: health legislation / mental health / mental health care / human rights. This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the organization. The document may, however, be freely reviewed, abstracted, reproduced or translated, in part or in whole, but not for sale or for use in conjunction with commercial purposes. Division of Mental Health and Prevention of Substance Abuse World Health Organization Geneva, 1996 TABLE OF CONTENTS Foreword 1. Promotion of Mental Health and Prevention of Mental Disorders 2. Access to Basic Mental Health Care 3. Mental Health Assessments in Accordance with Internationally Accepted Principles 4. Provision of the Least Restrictive Type of Mental Health Care 5. Self-Determination 6. Right to be Assisted in the Exercise of Self-Determination 7. Availability of Review Procedure 8. Automatic Periodical Review Mechanism 9. Qualified Decision-Maker 10. Respect of the Rule of Law FOREWORD This WHO reference document lists and describes ten basic principles of mental health care law. It also provides annotations for their implementation in practice. It is largely inspired from a comparative analysis of national mental health laws in a selection of 45 countries worldwide conducted by WHO in recent years. Also, this selection of principles draws from the Principles for the Protection of Persons with Mental Illness and the Improvement of Mental Health Care adopted by UN General Assembly Resolution 46/119 of 17 December 1991 (hereafter referred to as "UN Principles").
    [Show full text]
  • Incapacitation Through Maiming: Chemical Castration, the Eighth Amendment, and the Denial of Human Dignity John F
    University of Florida Levin College of Law UF Law Scholarship Repository Faculty Publications Faculty Scholarship 1-1-2006 Incapacitation Through Maiming: Chemical Castration, the Eighth Amendment, and the Denial of Human Dignity John F. Stinneford University of Florida Levin College of Law, [email protected] Follow this and additional works at: http://scholarship.law.ufl.edu/facultypub Part of the Constitutional Law Commons, Criminal Law Commons, and the Human Rights Law Commons Recommended Citation John F. Stinneford, Incapacitation Through Maiming: Chemical Castration, the Eighth Amendment, and the Denial of Human Dignity, 3 U. St. Thomas L. J. 559 (2006), available at http://scholarship.law.ufl.edu/facultypub/215 This Article is brought to you for free and open access by the Faculty Scholarship at UF Law Scholarship Repository. It has been accepted for inclusion in Faculty Publications by an authorized administrator of UF Law Scholarship Repository. For more information, please contact [email protected]. ARTICLE INCAPACITATION THROUGH MAIMING: CHEMICAL CASTRATION, THE EIGHTH AMENDMENT, AND THEDENIAL OF HUMAN DIGNITY JoHN F. STINNEFORD* There are limits to the extent to which a legislatively represented majority may conduct biological experiments at the expense of the dignity and personality and natural powers of a minority-even those who have been guilty of what the majority define as crimes.' To be 'cured' against one's will and cured of states which we may not regard as disease is to be put on a level with those who have not yet reached the age of reason or those who never will; to be classed with infants, imbeciles and domestic animals.' INTRODUCTION ..................................................
    [Show full text]
  • WHO Resource Book on Mental Health, Human Rights and Legislation
    WHO RESOURCE BOOK ON MENTAL HEALTH, HUMAN RIGHTS AND LEGISLATION Stop exclusion, dare to care World Health Organization WHO RESOURCE BOOK ON MENTAL HEALTH, HUMAN RIGHTS AND LEGISLATION Stop exclusion, dare to care WHO Library Cataloguing-in-Publication Data WHO Resource Book on Mental Health, Human Rights and Legislation. 1. Mental health 2. Human rights - legislation 3. Human rights - standards 4. Health policy - legislation 5. International law 6. Guidelines 7. Developing countries I.World Health Organization. ISBN 92 4 156282 X (NLM classification: WM 34) Technical information concerning this publication can be obtained from: Dr Michelle Funk Ms Natalie Drew Mental Health Policy and Service Development Team Department of Mental Health and Substance Dependence Noncommunicable Diseases and Mental Health Cluster World Health Organization CH-1211, Geneva 27 Switzerland Tel: +41 22 791 3855 Fax: +41 22 791 4160 © World Health Organization 2005 E-mail: [email protected] All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to Marketing and Dissemination, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • Distinguishing Dementia from Mental Illness and Other Causes of Decline
    Distinguishing Dementia from Mental Illness and Other Causes of Decline By Carolyn Reinach Wolf, Jamie A. Rosen, Dorothea Constas and Hindi Mermelstein I. INTRODUCTION Whether an individual suffers from dementia, mental illness or another cause of cognitive impairment, these conditions cause symptoms that worry potential clients, family members and caregivers, to the point of leading them to seek the advice of an attorney with experience in this area. Though there may be several legal questions that arise, in the end, all roads lead to capacity or lack thereof. Attorneys must develop the skill set to assess whether a client (or a client’s family member or loved one) has capacity in a variety of different situations according to various legal standards, and then advise that client as to how to best proceed to achieve his or her legal goal. The attorney must keep in mind his or her ethical obligations in representing a client with potential or actual diminished capacity. In cases where a client may be unable to make decisions on his or her own behalf due to some type of mental impairment (or where the client is a family member or loved one of a mentally impaired individual), that attorney must then develop a plan that may include executing appropriate legal planning documents or seeking intervention through the court system to protect the best interests of the individual. Section II will discuss the common clinical syndromes causing clinical dysfunction, with an emphasis on the similarities and differences between them. Section III will explore the issue of capacity and how these various symptoms affect legal representation from the perspective of a privately retained attorney and from the viewpoint of a Mental Hygiene Legal Service attorney.
    [Show full text]